Corrigendum: Evaluating the role of pericoronary adipose tissue on coronary artery disease: insights from CCTA on risk assessment, vascular stenosis, and plaque characteristics

Jingyue Wang, Huicong Zhang, Zihao Wang, Wenyun Liu, Dianbo Cao, Qian TongFrontiers in Cardiovascular Medicine 2024 · DOI · OpenAlex

This document serves as a formal corrigendum to the article "Evaluating the role of pericoronary adipose tissue on coronary artery disease: insights from CCTA on risk assessment, vascular stenosis, and plaque characteristics," originally published in Frontiers in Cardiovascular Medicine (DOI: 10.3389/fcvm.2024.1451807).

Administrative Transparency and the Version of Record

In scientific publishing, the "Version of Record" is the definitive, citable version of a research paper. Maintaining its accuracy is paramount, not only for the scientific data itself but also for the administrative and financial metadata associated with the work. This corrigendum addresses a clerical error in the funding statement of the original publication.

While such corrections do not alter the experimental results or clinical conclusions, they are essential for institutional and financial accountability. Grant numbers are the primary mechanism through which funding agencies track the impact and output of their investments. An incorrect number can lead to complications in auditing, reporting, and future grant eligibility.

The Correction: Funding Statement Update

The authors have identified an error in the grant number provided for the "National Key R&D Program of China." The original manuscript listed an incorrect identifier, which has now been rectified to ensure proper attribution.

Original Funding Statement (Incorrect): National Key R&D Program of China (Grant No.: 2022YFA0806400).

Corrected Funding Statement: National Key R&D Program of China (Grant No.: 2022YFC3601305).

The other supporting grants remain unchanged:

  • National Science Foundation of China (Grant No.: 82070362)
  • Jilin Province Special Project of Medical and Health Talents (Grant Nos.: JLSWSRCZX2023-9 and JLSWSRCZX2021-23)

Scientific Context: PCAT and Cardiovascular Risk

The underlying research corrected by this notice explores the clinical utility of pericoronary adipose tissue (PCAT)—the fat layer surrounding the coronary arteries—as a biomarker for coronary artery disease (CAD).

Traditional assessment of CAD often focuses on the degree of vascular stenosis (narrowing of the artery). However, the study utilizes Coronary Computed Tomography Angiography (CCTA) to measure the fat attenuation index (FAI). PCAT acts as a metabolic sensor; changes in its composition, detectable via CCTA, can indicate arterial inflammation before significant physical blockage occurs. This allows for a more nuanced risk assessment, potentially identifying high-risk patients who might be missed by traditional screening methods. The study also integrates Digital Subtraction Angiography (DSA) to evaluate plaque characteristics and stenosis severity.

Conclusion

The authors emphasize that this administrative update does not change the scientific conclusions of the article in any way. The data analysis, statistical results, and clinical interpretations regarding the role of PCAT in CAD risk assessment remain fully valid. This correction ensures that the financial support for this significant research is accurately documented for future reference and auditing.

Summary updated

Abstract

[This corrects the article DOI: 10.3389/fcvm.2024.1451807.].
BibTeX
@inproceedings{wang2024corrigendum,
  author = {Jingyue Wang and Huicong Zhang and Zihao Wang and Wenyun Liu and Dianbo Cao and Qian Tong},
  title = {{Corrigendum: Evaluating the role of pericoronary adipose tissue on coronary artery disease: insights from CCTA on risk assessment, vascular stenosis, and plaque characteristics}},
  booktitle = {Frontiers in Cardiovascular Medicine},
  year = {2024},
  doi = {10.3389/fcvm.2024.1531099},
}
Figure